Historically, the ISAGA was regarded as the gold standard for IgM detection, particularly in congenital toxoplasmosis, but changes in European regulations led to its commercial discontinuation in 2024 [58]. The gene discussed is CD40LG; the disease is congenital toxoplasmosis.